Navigation Links
Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
Date:8/5/2008

-Trial to Examine New Therapeutic Platform in Patients with Cystoid Macular

Edema-

SUNNYVALE, Calif., Aug. 5 /PRNewswire/ -- Icon Bioscience, Inc., (IBI), a privately held ophthalmic pharmaceutical company, announced today that enrollment has been completed in its Phase I clinical trial to assess the safety and efficacy of its lead product, IBI-20089, in patients with cystoid macular edema. This multi-site trial enrolled patients with cystoid macular edema associated with retinal vein occlusion and post operative cataract surgery.

IBI-20089 is a novel drug product based on IBI's proprietary Verisome(TM) drug delivery platform technology, which is optimally suited for application in the ophthalmic market. IBI-20089 is designed to last up to one year with a single intravitreal injection. It uniquely provides physicians the flexibility to tailor the duration of effect for a particular patient. IBI- 20089 is administered as a standard intravitreal injection without the need for additional devices or surgical procedures.

"We are pleased to have reached this important milestone. Our preliminary data confirms the safety and efficacy of our lead product, IBI-20089, as well as the versatility and flexibility of our underlying Verisome(TM) drug delivery technology," said Vernon G. Wong, MD, Founder of Icon Bioscience, Inc. "We believe IBI is creating the future standard of ophthalmic care as evidenced by the development of IBI-20089, the first of many products already in development based on the Verisome(TM) technology."

About Icon Bioscience, Inc.

Icon Bioscience, Inc. (IBI) is a privately held company focused on the development and commercialization of novel ophthalmic pharmaceuticals, based on its proprietary Verisome(TM) drug delivery platform. The Verisome(TM) drug delivery technology encompasses over twenty related but distinct novel and proprietary drug delivery systems optimally suited for appl
'/>"/>

SOURCE Icon Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Milliman, Inc., a premier ... of its 2013 Milliman Medical Index (MMI), which measures ... four receiving healthcare benefits through an employer-sponsored preferred provider ... typical family in 2013 is $22,030. ... prior year on a percentage basis was the lowest ...
(Date:5/22/2013)... May 22, 2013 Pomerantz Grossman ... claims on behalf of investors of Intuitive Surgical, Inc. ... ) (CUSIP: 46120E602) who purchased Intuitive Surgical common stock ... "Class Period"). Such investors are advised to contact ... or 888-476-6529, ext. 237. The investigation ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4
...  ZHUHAI, China, Oct. 24, 2011 ... a leading global manufacturer of electronic medical devices ... worldwide technology licensing agreement and the launch of ...  new generation of modular patient monitors. The agreement ...
... Mont., Oct. 24, 2011 Bacterin International ... leader in the development of revolutionary bone graft material and ... at the Singular Research,s Sixth Annual ,Best of the Uncovereds, ... Boulevard Hotel in Los Angeles, California. Bacterin,s chairman ...
Cached Medicine Technology:Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 2Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 3Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 4Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 5Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 6Bacterin to Present at Sixth Annual Singular Research 'Best of the Uncovereds' Conference on October 26, 2011 2
(Date:5/22/2013)... May 22 (HealthDay News) -- Over the next two ... States is expected to more than double, topping more ... The main factor driving the increase: an aging ... and the American Stroke Association, was published May 22 ... absolutely strain the health care system," Dr. Bruce Ovbiagele, ...
(Date:5/22/2013)... Award Presented at the 2013 Annual M&A ... http://bit.ly/13DkFfk , Merrill Corporation is pleased to ... of the Year” at the 7th M&A Advisor Turnaround ... in Palm Beach, Florida. , Merrill DataSite is ... solution that optimizes the due diligence process and offers ...
(Date:5/22/2013)... Hurricane preparation isn’t just about stocking up ... Amica Insurance is reminding everyone to review their ... , “An important part of hurricane preparedness is reviewing ... vice president at Amica Insurance. “The best time to ... a storm.” , Flood damage is not covered under ...
(Date:5/22/2013)... 2013 Finding trustworthy, loving child care is ... for their children. To help parents in their search, ... information about their nurturing programs, staff and much more. , ... spirit of Paty’s Daycare,” said Patricia “Auntie Paty” Sutton, founder ... you visit the new website, from the first time that ...
(Date:5/22/2013)... Milwaukee, WI (PRWEB) May 22, 2013 Unknown ... approaching their area at 30 mph. Minutes before it ... public of the nearing threat. This gave them time to ... Telcom & Data is proud to provide a product ... situation occurs. A Wheelock SAFEPATH® SP40S Emergency Evacuation System ...
Breaking Medicine News(10 mins):Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2
... number of air passengers arriving from Mexico, analysis shows, ... received the most airline passengers from Mexico this spring ... infection, new research says. , The finding confirms that ... disease may strike next could provide governments and public ...
... 29 CCA Industries, Inc. (NYSE Amex: CAW ... a $0.07 cash dividend payable to all shareholders of record ... consecutive dividend paid by the company. "In the meantime, ... to continue our consecutive dividend stream," stated David Edell, CEO. ...
... , , Orthopaedic surgeons provide safety tips for Fourth ... Fourth-of-July fireworks always draw a crowd but those ... used with care. This Independence Day, the American Academy ... spectacular celebrations but urges adults and children to exercise extreme caution ...
... , ... of the few surgeons in the Maryland specially trained to perform the latest minimally invasive ... ... Hungerford, M.D. has joined Mercy Medical Center as the 135-year-old downtown hospital,s ...
... often the victims of these falls, CDC says , ... than 47,000 elderly Americans are treated at hospital emergency ... canes, according to a federal government study released Monday. ... a day. , U.S. Centers for Disease Control and ...
... was the first effective treatment in the fight against malaria ... against this devastating disease. But the drug is associated with ... sickness and headaches to blindness, deafness and in rare cases ... Scientists at The University of Nottingham have made a discovery ...
Cached Medicine News:Health News:Air Traffic Patterns Predict Swine Flu Spread 2Health News:Air Traffic Patterns Predict Swine Flu Spread 3Health News:Fireworks Should Sparkle in the Sky 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 3Health News:47,000 Elderly Hurt in Walker, Cane Mishaps Each Year 2Health News:Breakthrough in combating the side effects of quinine 2
... channel platelet aggregation profiler combined with a ... with Microsoft WindowsTM, the PAP-4CD has real ... storage of test results, plus simplified data ... are available: chromogenic assays, von willebrand assay ...
Express Elyte Systems....
Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....
For the quantitative determination of iron, total iron-binding capacity in human serum....
Medicine Products: